Evidence map›Paper›PMID 18689558›Full record

Trial reportJournal of the American College of Nutrition2008

A dose-response study on the effects of purified lycopene supplementation on biomarkers of oxidative stress.

Sridevi Devaraj, Surekha Mathur, Arpita Basu, Hnin H Aung, Vihas T Vasu, Stuart Meyers, Ishwarlal Jialal

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American College of Nutrition, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02886832 (A Pilot, Open-label Study to Evaluate the Effects of a Prostate Health Formulation on Scores Attained From the International Prostate Symptom Score), which is not on this map. Cited by 44 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 6 pooled it
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02886832 nacompletednot on this mapstarted 2016, after this paper: background citation

A Pilot, Open-label Study to Evaluate the Effects of a Prostate Health Formulation on Scores Attained From the International Prostate Symptom Score (I-PSS) Questionnaire Among Overall Healthy Male Participants Who Report Lower Urinary Tract Complaints

TypeinterventionalSponsorSupplement Formulators, Inc.Ran2016 to 2018Enrolled30ConditionsProstate HealthArmsProstate Health formulation
3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 6 syntheses or guidelines pooled it, 146 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Supplementation with the antioxidant lycopene significantly decreases oxidative stress parameters and the bone resorption marker N-telopeptide of type I collagen in postmenopausal women.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2011
    Trial
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Veterinary research forum : an international quarterly journal · 2023
    Article
  17. Article
  18. Review
  19. Article
  20. Association of Plasma Carotenoid and Malondialdehyde Levels with Physical Performance in Korean Adolescents.International journal of environmental research and public health · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sridevi DevarajLaboratory for Atherosclerosis and Metabolic Research, University of California Davis Medical Center, 4635 2nd Avenue, Sacramento, CA 95817, USA.
Surekha Mathur
Arpita Basu
Hnin H Aung
Vihas T Vasu
Stuart Meyers
Ishwarlal Jialal
University of California Davis Medical Center · USUniversity of California, Davis · US

Funding

CLINICAL STUDIES IN NUTRITION AND METABOLISMK24AT000596 · NCCIH · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI JIALAL, ISHWARLAL · 2000 to 2009
$1.3M
NCCIH NIH HHS K24 AT000596NCCIH NIH HHS K24AT00596
6 · The paper itself

Abstract

objectiveWhile tomato product supplementation, containing antioxidant carotenoids, including lycopene, decreases oxidative stress, the role of purified lycopene as an antioxidant remains unclear. Thus, we tested the effects of different doses of purified lycopene supplementation on biomarkers of oxidative stress in healthy volunteers.

methodsThis was a double-blind, randomized, placebo-controlled trial, examining the effects of 8-week supplementation of purified lycopene, on plasma lycopene levels, biomarkers of lipid peroxidation {LDL oxidizability, malondialdehyde & hydroxynonenals (MDA & HNE), urinary F(2)-isoprostanes}, and markers of DNA damage in urine and lymphocytes. Healthy adults (n = 77, age > or = 40 years), consumed a lycopene-restricted diet for 2 weeks, and were then randomized to receive 0, 6.5, 15, or 30 mg lycopene/day for 8 weeks, while on the lycopene-restricted diet. Blood and urine samples were collected at the beginning and end of Week 2 of lycopene-restricted diet, and at end of Week 10 of the study.

resultsIndependent of the dose, plasma lycopene levels significantly increased in all lycopene supplemented groups versus placebo (p < 0.05). ANOVA revealed a significant decrease in DNA damage by the comet assay (p = 0.007), and a significant decrease in urinary 8-hydroxy deoxoguanosine (8-OHdG) at 8 weeks versus baseline (p = 0.0002), with 30 mg lycopene/day. No significant inter- or intra-group differences were noted for glucose, lipid profile, or other biomarkers of lipid peroxidation at any dose/time point.

conclusionsThus, purified lycopene was bioavailable and was shown to decrease DNA oxidative damage and urinary 8-OHdG at the high dose.

Indexed as

8-Hydroxy-2'-DeoxyguanosineAdultAldehydesAntioxidantsBiomarkersBlood GlucoseCarotenoidsComet AssayDeoxyguanosineDietary SupplementsDNADNA DamageDose-Response Relationship, DrugDouble-Blind MethodF2-IsoprostanesHumans8-Hydroxy-2'-DeoxyguanosineAldehydesAntioxidantsBiomarkersBlood GlucoseCarotenoidsDeoxyguanosineDNAF2-IsoprostanesLipoproteins, LDLLycopeneMalondialdehydeoxidized low density lipoproteintert-4-hydroxy-2-nonenal

Identifiers

PMID18689558
PMCPMC2677959
OpenAlexW2065406033

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.